Another opioid reversal drug approved by FDA

By Jenny Goldsberry

Published July 28, 2023 11:40pm ET

Add Washington Examiner on Google

Another opioid reversal drug approved by FDA — President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File) | Andrew Harnik

The Food and Drug Administration approved a second drug Friday to battle opioid overdoses.

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Drug Policy Drugs FDA Opioids Opium